Non-alcoholic fatty liver disease as a determinant of cardiovascular disease
- PMID: 16828776
- DOI: 10.1016/j.atherosclerosis.2006.06.004
Non-alcoholic fatty liver disease as a determinant of cardiovascular disease
Comment on
-
Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.Diabetes Metab Res Rev. 2006 Nov-Dec;22(6):437-43. doi: 10.1002/dmrr.666. Diabetes Metab Res Rev. 2006. PMID: 16832839 Review.
Similar articles
-
Non-alcoholic fatty liver disease guidelines: an Asian perspective.J Gastroenterol Hepatol. 2007 Jun;22(6):769-70. doi: 10.1111/j.1440-1746.2007.05015.x. J Gastroenterol Hepatol. 2007. PMID: 17565626 No abstract available.
-
[Influence of non-alcoholic fatty liver disease on cardiovascular disease].Gastroenterol Hepatol. 2012 Oct;35(8):585-93. doi: 10.1016/j.gastrohep.2012.02.005. Epub 2012 Apr 26. Gastroenterol Hepatol. 2012. PMID: 22541252 Review. Spanish.
-
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.Nutr Metab Cardiovasc Dis. 2007 Nov;17(9):684-98. doi: 10.1016/j.numecd.2007.01.007. Epub 2007 Jun 7. Nutr Metab Cardiovasc Dis. 2007. PMID: 17560098 Review.
-
Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.J Gastroenterol Hepatol. 2007 Mar;22(3):293-303. doi: 10.1111/j.1440-1746.2007.04824.x. J Gastroenterol Hepatol. 2007. PMID: 17295757 Review.
-
[Non-alcoholic fatty liver disease. How and who to screen].Gastroenterol Hepatol. 2011 Apr;34(4):278-88. doi: 10.1016/j.gastrohep.2010.11.010. Epub 2011 Mar 22. Gastroenterol Hepatol. 2011. PMID: 21429628 Review. Spanish.
Cited by
-
Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids.Diabetologia. 2013 Oct;56(10):2266-74. doi: 10.1007/s00125-013-2981-2. Epub 2013 Jul 4. Diabetologia. 2013. PMID: 23824212 Free PMC article.
-
Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis.Int J Endocrinol. 2013;2013:124958. doi: 10.1155/2013/124958. Epub 2013 Apr 10. Int J Endocrinol. 2013. PMID: 23690766 Free PMC article.
-
Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH.Metabolites. 2022 Mar 11;12(3):238. doi: 10.3390/metabo12030238. Metabolites. 2022. PMID: 35323681 Free PMC article. Review.
-
Tyrosol Attenuates High Fat Diet-Induced Hepatic Oxidative Stress: Potential Involvement of Cystathionine β-Synthase and Cystathionine γ-Lyase.Lipids. 2016 May;51(5):583-90. doi: 10.1007/s11745-015-4084-y. Epub 2015 Oct 30. Lipids. 2016. PMID: 26518313
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical